Experience with combination of cetuximab plus intensity-modulated radiotherapy with or without chemotherapy for locoregionally advanced nasopharyngeal carcinoma

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

James A. Bonner, Paul M. Harari, J. Giralt et al. · New England Journal of Medicine · 2006 · 5.1K citations · Full text

Medicine, Oncology, Radiation Oncology +13

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

Muhyi Al‐Sarraf, Michael LeBlanc, Padmini Giri et al. · Journal of Clinical Oncology · 1998 · 2.2K citations

Medicine, Oncology, Radiation Oncology +13

Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

K. Kian Ang, Brian Berkey, Xiaoyu Tu et al. · PubMed · 2002 · 1.2K citations

Medicine, Oncology, Carcinogenesis +13

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

S. Huang, Jonathan M. Bock, Paul M. Harari · PubMed · 1999 · 718 citations

Medicine, Cell Biology, Oncology +17

Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience

Suzanne L. Wolden, William Chen, David G. Pfister et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 421 citations

Medicine, Oncology, Radiation Oncology +13